Poster presenters are required to prepare and put up their poster according to the guidelines below.
Each presenter will be allocated to a board number to display their poster. Board number can be found on the top left-hand of the poster board.
Presenters are required to strictly adhere to the abstract and board number advised to them as the numberings will be reflected in the scientific e-programme book.
Poster Specifications
Abstract Number: To be included at the top left-hand corner of poster
Poster dimensions: 1186mm high x 900mm wide, PORTRAIT orientation is required
Content: Please ensure that the font size for your text content is at least point 24. Larger font size is expected for the abstract titles, authors, and sub-headings. You are required to include your abstract number, authors’ names, affiliations, and countries in the poster.
Poster Display
Location: Posters will be displayed in the Exhibition Hall FGH, located on the Ground Level in the Central Building of the Adelaide Convention Centre.
Set-up, Display and Removal Schedule
Date | Session | Time |
8 Sept |
Set up Time Coffee-Breaks Lunch Breaks |
07:00 – 08:00 10:05 – 10:50 / 16:50 – 17:20 12:20 – 13:50 |
9 Sept |
Coffee-Breaks Lunch Breaks |
09:30 – 10:15 / 14:45 – 15:30 11:45 – 13:15 |
10 Sept |
Coffee-Breaks Dismantle |
10:40 – 11:10 12:30 – 13:30 |
If you have any questions about the information about, email aspire@theconferencecompany.com.
FEATURED Poster Presentations
Young Investigator Awardee / Shortlisted Poster Presentations
Abstract Number | Abstract Title | Abstract Theme | Presenting Author | Poster Board Number |
60 | IS THE IMBALANCE OF GENDER RATIO (GR) IN IVF/ICSI CYCLES BEING AFFECTED BY CURRENT BLASTOCYST SELECTION CRITERIA? | Embryology | Miss Zhi Xuan Teng | P1 |
96 | THE EFFICACY OF PLATELET RICH PLASMA THERAPY IN THIN ENDOMETRIUM UNDERGOING FROZEN THAWED EMBRYO TRANSFER IN ASSISTED REPRODUCTIVE TECHNOLOGY: A SYSTEMATIC REVIEW AND META-ANALYSIS | ART Clinical | Mrs Laili Chilmawati | P2 |
101 | A DIRECT HEALTHCARE COST ANALYSIS OF RECOMBINANT LH VERSUS HMG SUPPLEMENTATION ON FSH DURING CONTROLLED OVARIAN HYPERSTIMULATION IN THE GNRH-ANTAGONIST PROTOCOL |
ART Clinical |
Mrs Jui-Chun Chang |
P3 |
113 | TRANSDERMAL OESTROGEN (GEL) FOR ENDOMETRIAL PREPARATION IN FROZEN-THAWED EMBRYO TRANSFER |
ART Clinical |
Dr Rahilah Ahmad Shukri |
P4 |
193 | COMPARISON OF THE DIFFERENT EXPRESSION OF OCT-4, GATA-3 AND CLINICAL PREGNANCY OUTCOME BETWEEN THE DAY 5 AND DAY 6 BLASTOCYSTS |
ART, Basic Research |
Ms Jui-Hua Lee |
P5 |
82 | DOES APOPTOTIC BODY IMPAIR PREGNANCY OUTCOME |
ART, Laboratory |
Ms Nur Ilanah Rosli |
P6 |
146 | LOW-LACTATE CULTURE MEDIUM INCREASES THE PERCENTAGE OF USABLE BLASTOCYSTS FROM ADVANCED MATERNAL AGE PATIENTS: A SIBLING-OOCYTE, MONOCENTRIC STUDY. |
ART, Laboratory |
Dr Hiromitsu Hattori |
P7 |
273 | COMPARATIVE ANALYSIS OF PREGNANCY PREDICTIVE POTENTIAL USING THE DEEP LEARNING BLASTOCYST SCORING MODEL CALCULATED FROM THE SINGLE FOCUS BLASTOCYST IMAGE AND TIME-LAPSE IMAGE SEQUENCES |
ART, Laboratory |
Mr Masashi Shioya |
P8 |
319 | BLASTOCYST FORMATION PREDICTION BASED ON DEEP LEARNING MODEL FROM 3-DAY EMBRYO IMAGES IN TIME-LAPSE INCUBATOR USING DATA AUGMENTATION |
ART, Laboratory |
Mr Sangho Lee |
P9 |
231 | ASSOCIATION BETWEEN REDUCED MUSCLE MASS AND OBESITY ON VARIOUS METABOLIC RISK FACTORS AND FRACTURE RISK IN MID-AGED KOREAN WOMEN |
Menopause |
In Hye Kim |
P10 |
361 | WHAT DOES MY EMBRYO SCORE MEAN? THE RELATIONSHIP BETWEEN KIDSCORE, LIFE WHISPERER AI SCORE, AND EMBRYO EUPLOIDY |
Preimplantation Screening and Diagnosis |
Dr Ying-Chen Soo |
P11 |